My name is Michał Brzdęk. I am a medical doctor currently specializing in gastroenterology, with a strong research background in hepatology—particularly chronic hepatitis C, liver cirrhosis, and its complications. Over the past several years, I have co-authored almost 40 peer-reviewed scientific publications, many of which focus on the management and outcomes of liver disease in real-world clinical settings. My research interests include the effectiveness and safety of direct-acting antivirals in patients infected with HCV, as well as the complications of cirrhosis, such as portal hypertension. I am especially proud of my contributions to multicenter studies that have provided valuable insights into the clinical profiles and outcomes of patients with liver-related comorbidities. I am committed to advancing evidence-based hepatology through active collaboration with leading academic centers. My work has been published in respected journals such as World Journal of Gastroenterology, Polish Archives of Internal Medicine, and Journal of Clinical Medicine. My current ResearchGate profile shows over 222 citations and an h-index of 9. My total Impact Factor has reached approximately 100. I am also an active member of several professional societies, including the European Association for the Study of the Liver (EASL), the Polish Society of Hepatology (PTH), and the Polish Society of Gastroenterology (PTG-E).